Jennifer Jones
About Jennifer Jones
Company
Jennifer Jones is currently working at Bristol Myers Squibb as Director, Pharmacodiagnostics, Translational Sciences and Diagnostics. Based in New Jersey, United States, she leads strategic and operational aspects of the pharmacodiagnostics programs for various therapeutic areas.
Title
Jennifer Jones holds the title of Director, Pharmacodiagnostics, Translational Sciences and Diagnostics at Bristol Myers Squibb. She manages and drives the execution of diagnostic strategies for programs involving oncology, hematology, and other specialized medical fields.
Education and Expertise
Jennifer Jones studied at Rutgers University, where she earned a Master's of Business and Science in Drug Discovery and Development from 2020 to 2023. She also studied at Boston College from 1990 to 1994. She is certified as a Six Sigma Black Belt and an ASQ Quality Auditor, showcasing her qualifications in quality management and process improvement.
Professional Background
Jennifer has accumulated significant professional experience over the years. She previously worked at Bristol Myers Squibb as Associate Director, Pharmacodiagnostics from 2018 to 2020. Her diverse career also includes roles such as Manager at Biocartis for 2 months in 2018, Manager at Johnson & Johnson’s Janssen Diagnostics for 3 months from 2017 to 2018, and Senior Scientist at Ortho Clinical Diagnostics from 2001 to 2003. Her initial years in the industry were spent at Johnson & Johnson, where she served in multiple capacities, including Scientist and Sr. Scientist from 1997 to 2017.
Achievements and Responsibilities
Jennifer Jones has extensive experience in in vitro diagnostic design, development, registration, and commercialization. She is involved in partner selection and management, contracting, and defining diagnostic program strategies. Her work spans various medical fields including oncology, hematology, liver fibrosis, cardiovascular diseases, and gene therapy. Jennifer collaborates with internal and external partners to deliver diagnostic solutions, assisting in strategy execution for multiple high-impact projects.